OtherArticle
3,4-DEHYDRODEBRISOQUINE, A NOVEL DEBRISOQUINE METABOLITE FORMED FROM 4-HYDROXYDEBRISOQUINE THAT IMPACTS THE CYP2D6 METABOLIC RATIO
Yueying Zhen, Ondrej Slanar, Kristopher Krausz, Chi Chen, Josef Slavik, Kerry L. McPhail, T. Mark Zabriskie, Frantisek Perlik, Frank J. Gonzalez and Jeffrey R. Idle
Drug Metabolism and Disposition June 16, 2006, DOI: https://doi.org/10.1124/dmd.105.008920
Yueying Zhen
Ondrej Slanar
Kristopher Krausz
Chi Chen
Josef Slavik
Kerry L. McPhail
T. Mark Zabriskie
Frantisek Perlik
Frank J. Gonzalez
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
3,4-DEHYDRODEBRISOQUINE, A NOVEL DEBRISOQUINE METABOLITE FORMED FROM 4-HYDROXYDEBRISOQUINE THAT IMPACTS THE CYP2D6 METABOLIC RATIO
Yueying Zhen, Ondrej Slanar, Kristopher Krausz, Chi Chen, Josef Slavik, Kerry L. McPhail, T. Mark Zabriskie, Frantisek Perlik, Frank J. Gonzalez and Jeffrey R. Idle
Drug Metabolism and Disposition June 16, 2006, DOI: https://doi.org/10.1124/dmd.105.008920
OtherArticle
3,4-DEHYDRODEBRISOQUINE, A NOVEL DEBRISOQUINE METABOLITE FORMED FROM 4-HYDROXYDEBRISOQUINE THAT IMPACTS THE CYP2D6 METABOLIC RATIO
Yueying Zhen, Ondrej Slanar, Kristopher Krausz, Chi Chen, Josef Slavik, Kerry L. McPhail, T. Mark Zabriskie, Frantisek Perlik, Frank J. Gonzalez and Jeffrey R. Idle
Drug Metabolism and Disposition June 16, 2006, DOI: https://doi.org/10.1124/dmd.105.008920
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement